T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gen Digital
GEN
|
+$2.03B |
| 2 |
DuPont de Nemours
DD
|
+$1.83B |
| 3 |
Crown Castle
CCI
|
+$1.58B |
| 4 |
Microsoft
MSFT
|
+$1.48B |
| 5 |
TransUnion
TRU
|
+$781M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$1.72B |
| 2 |
Starbucks
SBUX
|
+$1.59B |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$1.3B |
| 4 |
Lowe's Companies
LOW
|
+$1.13B |
| 5 |
Philip Morris
PM
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.97% |
| 2 | Financials | 16.84% |
| 3 | Technology | 15.92% |
| 4 | Consumer Discretionary | 13.45% |
| 5 | Industrials | 10.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
NVR
NVR
$16.8B
| $17.1M | ﹤0.01% |
5,989
-1,146
| -16% | -$3.07M |
|
1227
Everest Group
EG
$13.9B
| $16.9M | ﹤0.01% |
74,169
-1,665
| -2% | -$420K |
|
1228
Seagate
STX
$209B
| $16.9M | ﹤0.01% |
508,155
-36,924
| -7% | -$1.25M |
|
1229
Repligen
RGEN
$9.45B
| $16.7M | ﹤0.01% |
436,618
+46,830
| +12% | +$1.96M |
|
1230
TIM SA
TIMB
$8.69B
| $16.7M | ﹤0.01% |
915,003
-5,584,781
| -86% | -$97M |
|
1231
Diageo
DEO
$52.8B
| $16.7M | ﹤0.01% |
126,044
-2,600
| -2% | -$336K |
|
|
ESTE
1232
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $16.6M | ﹤0.01% |
1,513,138
+155,435
| +11% | +$1.52M |
|
1233
Harley-Davidson
HOG
$2.7B
| $16.6M | ﹤0.01% |
344,502
-631,327
| -65% | -$30.7M |
|
|
SUPV
1234
Grupo Supervielle
SUPV
$725M
| $16.6M | ﹤0.01% |
671,530
+199,730
| +42% | +$3.93M |
|
|
VAR
1235
DELISTED
Varian Medical Systems, Inc.
VAR
| $16.6M | ﹤0.01% |
165,567
-913
| -0.5% | -$93.7K |
|
1236
NETSCOUT
NTCT
$2.87B
| $16.6M | ﹤0.01% |
511,858
+149,772
| +41% | +$5M |
|
1237
Phibro Animal Health
PAHC
$1.37B
| $16.5M | ﹤0.01% |
446,369
+38,386
| +9% | +$1.44M |
|
1238
Western Union
WU
$2.34B
| $16.5M | ﹤0.01% |
858,242
-28,237
| -3% | -$538K |
|
1239
Zions Bancorporation
ZION
$10.5B
| $16.4M | ﹤0.01% |
347,008
-3,010
| -0.9% | -$134K |
|
1240
Campbell Soup
CPB
$6.94B
| $16.3M | ﹤0.01% |
349,059
-7,897
| -2% | -$400K |
|
1241
Stepan Co
SCL
$1.48B
| $16.3M | ﹤0.01% |
195,059
+17,990
| +10% | +$1.48M |
|
|
CPN
1242
DELISTED
Calpine Corporation
CPN
| $16.3M | ﹤0.01% |
1,102,937
-1,914,339
| -63% | -$27.3M |
|
1243
CALL
CVS Health
CVS
$121B
| $16.3M | ﹤0.01% |
+200,000
| New | +$15.8M |
|
1244
Howmet Aerospace
HWM
$113B
| $16.2M | ﹤0.01% |
851,058
-5,086,882
| -86% | -$97.4M |
|
|
KS
1245
DELISTED
KapStone Paper and Pack Corp.
KS
| $16.2M | ﹤0.01% |
754,237
+248,411
| +49% | +$5.52M |
|
|
BOLD
1246
DELISTED
Audentes Therapeutics, Inc
BOLD
| $16.2M | ﹤0.01% |
578,342
-23,600
| -4% | -$512K |
|
1247
Coherus Oncology
CHRS
$176M
| $16.2M | ﹤0.01% |
1,211,472
+528,020
| +77% | +$6.98M |
|
1248
CALL
O'Reilly Automotive
ORLY
$74.5B
| $16.2M | ﹤0.01% |
+1,125,000
| New | +$14.9M |
|
1249
Nasdaq
NDAQ
$54.6B
| $16.1M | ﹤0.01% |
621,894
-606
| -0.1% | -$15.1K |
|
1250
Eagle Materials
EXP
$6.47B
| $16.1M | ﹤0.01% |
150,572
+39,148
| +35% | +$3.73M |
|
Similar funds
T. Rowe Price Associates's Q3 2017 Portfolio in Review
As of Q3 2017, T. Rowe Price Associates held 2,642 positions worth $585B, up 5.3% from $556B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
T. Rowe Price Associates's Q3 2017 filing shows 88 new, 1,025 increased, 900 reduced and 73 closed positions. Its largest new stake was Brighthouse Financial: 4,532,679 shares worth $276M. The largest sale was Du Pont De Nemours E I, an estimated $1.72B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q3 2017 buy was Brighthouse Financial: 4,532,679 shares worth $276M.
- T. Rowe Price Associates added most to Gen Digital in Q3 2017, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q3 2017 reduction was Starbucks, cutting an estimated $1.59B.
- T. Rowe Price Associates fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.72B.
- T. Rowe Price Associates's ten largest holdings make up 18% of its $585B portfolio in Q3 2017.
- T. Rowe Price Associates opened 88 new positions and closed 73 in Q3 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $585B.
Based on T. Rowe Price Associates's 13F filing for Q3 2017, filed 14 Nov 2017.